Evidence map›Paper›PMID 39279777›Full record

ArticleNeuro-oncology practice2024

The impact of brain cancer care coordinators on healthcare utilization and outcomes in patients with glioblastoma.

Martin Hong, Lucy Leigh, Connor Ballinger, Penny Reeves, Alisha Gooley, Sandy Nixon, Chris Paul, James Lynam

Abstract read
In one paragraph

Article in Neuro-oncology practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Martin HongDepartment of Medical Oncolgy, Liverpool Hospital, Liverpool, New South Wales, Australia.ORCID https://orcid.org/0000-0002-2327-4261
Lucy LeighData Sciences, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Connor BallingerHealth Economics, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Penny ReevesHealth Economics, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Alisha GooleyDepartment of Neurosurgery, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
Sandy NixonDepartment of Neurosurgery, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
Chris PaulSchool of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
James LynamDepartment of Medical Oncolgy, Calvary Mater Newcastle, Waratah, New South Wales, Australia.ORCID https://orcid.org/0000-0002-6742-820X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cancer care coordinators (CCCs) are recognized as having an important role in patients' and carers' cancer journey. However, there are no studies investigating the impact of CCCs on quantitative outcomes. We performed a retrospective cohort study investigating the impact of brain cancer care coordinators (BCCCs) on health service resource use and survival in patients with glioblastoma. Methods: All patients diagnosed with glioblastoma between 2012 and 2019 in Hunter New England Local Health District, Australia (HNELHD) were included and the patients were divided into 2 cohorts: before and after the introduction of the BCCC. Any patient diagnosed in 2016, during the introduction of the BCCC, were excluded. The main outcomes assessed were overall survival, health service resource use, odds of being admitted to hospital after the emergency presentation, and cost-offset analysis to examine the economic implications of BCCCs. Results: A total of 187 patients were included. There were no significant differences in overall survival between the 2 groups (mOS 12.0 vs 11.16 months, HR 0.95). However, there was a reduction in the number of ED presentations and admissions. This was associated with a 24% reduction in aggregate length of stay with the BCCC. There was no statistically significant difference in mean patient costs, however our hospital may have saved over AUD$500 000 with BCCCs. Conclusions: The introduction of BCCC did not improve survival but appeared to be associated with reduced health resource utilization. This study provides economic justification, in addition to the established quality of life improvements, to support the presence of BCCCs.

Indexed as

care pathwayglioblastomaglioblastoma patientshealth economicssupportive care

Identifiers

PMID39279777
PMCPMC11398931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.